10 employees
Facile Therapeutics is a biotechnology company that develops therapeutic drugs for clostridium difficile infection.
2017
$1.3M
from 2 investors over 2 rounds
Facile Therapeutics, Inc raised $1.3M on February 10, 2020
Investors: CARB-X
Facile Therapeutics, Inc raised undisclosed on September 1, 2019
Investors: Berkeley SkyDeck